1. Home
  2. FLGT vs AVK Comparison

FLGT vs AVK Comparison

Compare FLGT & AVK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fulgent Genetics Inc.

FLGT

Fulgent Genetics Inc.

HOLD

Current Price

$14.88

Market Cap

525.3M

Sector

Health Care

ML Signal

HOLD

Logo Advent Convertible and Income Fund

AVK

Advent Convertible and Income Fund

HOLD

Current Price

$12.37

Market Cap

553.6M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
FLGT
AVK
Founded
2011
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
525.3M
553.6M
IPO Year
2016
2003

Fundamental Metrics

Financial Performance
Metric
FLGT
AVK
Price
$14.88
$12.37
Analyst Decision
Buy
Analyst Count
3
0
Target Price
$28.33
N/A
AVG Volume (30 Days)
402.1K
155.4K
Earning Date
05-01-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$18,730,000.00
N/A
Revenue This Year
$10.09
N/A
Revenue Next Year
$12.18
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.46
$10.77
52 Week High
$31.04
$13.10

Technical Indicators

Market Signals
Indicator
FLGT
AVK
Relative Strength Index (RSI) 37.20 56.90
Support Level $14.23 $12.24
Resistance Level $16.76 $12.64
Average True Range (ATR) 0.59 0.18
MACD 0.01 0.02
Stochastic Oscillator 24.45 62.86

Price Performance

Historical Comparison
FLGT
AVK

About FLGT Fulgent Genetics Inc.

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in the laboratory services business and the therapeutic development business. The laboratory services business, which generates key revenue, includes technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue, and Foreign.

About AVK Advent Convertible and Income Fund

Advent Convertible & Income Fund is a diversified, closed-end management investment company. The fund's investment objective is to provide total return through a combination of capital appreciation and current income. The Fund invests in various sectors, such as communications, utilities, energy, industrial, technology, and others.

Share on Social Networks: